Oncology and Hematology
Episodes 1-16 of 77
Harry Yoon, MD
Jaffer Ajani, MD
- MinuteCE®
Effective Monitoring and Management of Adverse Effects in Metastatic ESCC
0.75 program creditsHarry Yoon, MD
Jaffer Ajani, MD
- MinuteCE®
Tailoring First-Line Regimens: Patient-Centric Selection in Metastatic ESCC
0.75 program creditsHarry Yoon, MD
Jaffer Ajani, MD
Jaffer Ajani, MD
Harry Yoon, MD
Jaffer Ajani, MD
- MinuteCE®
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
0.75 program creditsHarry Yoon, MD
Harry Yoon, MD
Jaffer Ajani, MD
- MinuteCE®
Strategies for Navigating First-Line Treatment Selection in Metastatic ESCC
0.75 program creditsHarry Yoon, MD
Jaffer Ajani, MD
Daniel P. Petrylak, MD
Elizabeth R. Plimack, MD, MS, FASCO
Evan Y. Yu, MD
Nathan A. Boggs, MD
Tracy George, MD
Lindsay Rein, MD
Nathan A. Boggs, MD
Tracy George, MD
Lindsay Rein, MD
Nathan A. Boggs, MD
Tracy George, MD
Lindsay Rein, MD
Nathan A. Boggs, MD
Tracy George, MD
Lindsay Rein, MD
Nathan A. Boggs, MD
Tracy George, MD
Lindsay Rein, MD
Heather McArthur, MD
Margaret Gatti-Mays, MD, MPH
Pasi Antero Jänne, MD, PhD
Helena Yu, MD
- Prev
- Next